Description

Cutting-Edge Retatrutide 20mg 

At GLP1 Peptides, we provide the scientific community with access to the most innovative compounds in metabolic research. Retatrutide 20mg represents a significant evolution in peptide science, acting as a unimolecular triple agonist.

Unlike traditional single or dual agonists, Retatrutide 20mg is engineered to engage three distinct pathways:

1. GLP-1 (Glucagon-Like Peptide-1)

2. GIP (Glucose-Dependent Insulinotropic Polypeptide)

3. GR (Glucagon Receptor)

This multi-receptor approach makes it an essential tool for researchers investigating complex metabolic signaling and energy homeostasis at higher concentrations.

The GLP1 Peptides Quality Standard

• 99% Purity Levels: Every batch of Retatrutide 20mg is verified through HPLC and Mass Spectrometry to ensure it meets the highest industry benchmarks for purity.

• Advanced Lyophilization: Our professional freeze-drying process preserves the peptide’s delicate molecular bonds, ensuring long-term stability and a reliable shelf life.

• Analytical Transparency: Every shipment is accompanied by a batch-specific Certificate of Analysis (COA), ensuring researchers have the data integrity required for credible results.

• Precision Synthesis: Our laboratory focuses on the exact amino acid sequencing necessary for high-level metabolic studies.

Technical Product Specifications:

• Compound Name: Retatrutide

• Concentration: 20mg Single Compound

• Format: Lyophilized Crystalline Powder

• Target Receptors: GLP-1, GIP, and Glucagon

• Purity Rating: >99%

• Storage: Lyophilized peptides should be stored at -20°C for long-term stability.